OpenAlex
PricingAboutJobs
Log inGet started
Work

Bcl-2/Bcl-xL Inhibition Increases the Efficacy of MEK Inhibition Alone and in Combination with PI3 Kinase Inhibition in Lung and Pancreatic Tumor Models

HTML

Year: 2013
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-12-0949
Authors: Nguyen Tan, Maureen Wong, Michelle A. Nannini, Rebecca Hong, Leslie B. Lee, Stephen Price, Karen Williams, Pierre Pascal Savy, Peng Yue, Deepak Sampath, Jeffrey Settleman, Wayne J. Fairbrother, Lisa D. Belmont
Language: English

Topic: Cell death mechanisms and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: MEK inhibition, navitoclax, PI3K inhibition, GDC-0941, combination therapy, non-small cell lung cancer, pancreatic cancer, KRAS mutation, apoptosis, MAPK signaling, PI3K signaling, synergistic drug combination, cell cycle arrest, xenograft models
SDG: Good health and well-being

Open Access status: closed

Funders: Prevent Cancer Foundation, Abbott Laboratories
OpenAlex ID: W2135675362
FWCI: 3.025
Cites: 48
Cited by: 86
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security